NCT02902822
- Conditions
- Actinic Keratosis, Alzheimer Disease, Bacterial Infections, +56 more
- Locations
-
- Local Health Authority (ATS) Bergamo, Italy
Clinical trial condition
Impetigo
Explore clinical trials studying Impetigo. Study availability and eligibility vary by location and protocol.
26 public trials
1 recruiting study
Impetigo trial results
NCT03429595
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +9 more
- Locations
-
- AntibioTx Investigational Site Bloemfontein, South Africa
- AntibioTx Investigative Site Boksburg, South Africa
- AntibioTx Investigative Site Claremont, South Africa
- AntibioTx Investigative Site Durban, South Africa
NCT00852540
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Cellulitis, +16 more
- Locations
-
- GSK Investigational Site Anniston, Alabama, United States
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Bentonville, Arkansas, United States
- GSK Investigational Site Jonesboro, Arkansas, United States
NCT00133874
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Cellulitis, +16 more
- Locations
-
- GSK Investigational Site Winnipeg, Manitoba, Canada
- GSK Investigational Site Winnipeg, Manitoba, Canada
- GSK Investigational Site St. John's, Newfoundland and Labrador, Canada
- GSK Investigational Site Brampton, Ontario, Canada
NCT00555061
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Cellulitis, +23 more
- Locations
-
- GSK Investigational Site Tuscaloosa, Alabama, United States
- GSK Investigational Site Bentonville, Arkansas, United States
- GSK Investigational Site Orange, California, United States
- GSK Investigational Site Woburn, Massachusetts, United States
NCT00133848
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +9 more
- Locations
-
- GSK Investigational Site Bangalore, India
- GSK Investigational Site Hyderabad, India
- GSK Investigational Site Rome, Lazio, Italy
- GSK Investigational Site Zapopan, Jalisco, Jalisco, Mexico
Completed
Efficacy and Safety of Ozenoxacin 1% Cream Versus Placebo in the Treatment of Patients With Impetigo
NCT01397461
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +9 more
- Locations
-
- Georg Popp Augsburg, Germany
- Klaus Chelius Cologne, Germany
- Roland Aschoff Dresden, Germany
- Diamant Thaci Frankfurt am Main, Germany
NCT01126268
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +23 more
- Locations
-
- Houston Medical Center Building Houston, Texas, United States
NCT01445600
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Cellulitis, +16 more
- Locations
-
- GSK Investigational Site Seoul, South Korea
NCT01670032
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +9 more
- Locations
-
- SRCR, Inc Bell Gardens, California, United States
- Skin Care research Inc Boca Raton, Florida, United States
- Eastern Research, Inc Hialeah, Florida, United States
- Cyn3rgy Research Gresham, Oregon, United States